MedTrace Logo

Korean Registry of Target Organ Damages in Hypertension

NCT01861080 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2019-02-08

No results posted yet for this study

Summary

The objective of this study is to know prevalence of clinical or subclinical target organ damages in Korea hypertensives by constructing nationwide hypertension registry. We will register 5000 consecutive patients with incident hypertension at 20 major university hospitals in South Korea. We will investigate clinical/subclinical target organ damages, renin/aldosterone level and cardiovascular events in each patient.

Conditions

Sponsors & Collaborators

  • Dongtan Sacred Heart Hospital

    lead OTHER

Principal Investigators

  • Kyu-Hyung Ryu, MD, PhD · Dongtan Sacred Heart Hospital, Hallym University

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01861080 on ClinicalTrials.gov